Anthony Petrone
Stock Analyst at Mizuho
(3.99)
# 662
Out of 4,753 analysts
160
Total ratings
53.51%
Success rate
10.33%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOLX Hologic | Maintains: Outperform | $90 → $87 | $71.58 | +21.54% | 8 | Nov 5, 2024 | |
| TFX Teleflex | Maintains: Neutral | $275 → $250 | $174.90 | +42.94% | 7 | Nov 1, 2024 | |
| LIVN LivaNova | Maintains: Outperform | $80 → $70 | $48.25 | +45.08% | 7 | Oct 31, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $100 → $110 | $103.54 | +6.24% | 8 | Oct 24, 2024 | |
| ABT Abbott Laboratories | Maintains: Neutral | $115 → $130 | $129.10 | +0.70% | 4 | Oct 17, 2024 | |
| ADMA ADMA Biologics | Maintains: Buy | $12 → $14 | $16.90 | -17.16% | 6 | Jun 20, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $65 → $70 | $30.73 | +127.83% | 6 | Jun 6, 2024 | |
| ALC Alcon | Maintains: Buy | $100 → $105 | $91.57 | +14.67% | 8 | May 15, 2024 | |
| STAA STAAR Surgical Company | Maintains: Buy | $53 → $55 | $23.22 | +136.86% | 7 | May 8, 2024 | |
| LNTH Lantheus Holdings | Maintains: Buy | $90 → $100 | $91.80 | +8.93% | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $105 | $86.93 | +20.79% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $16 | $5.13 | +211.89% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $85 → $100 | $154.32 | -35.20% | 6 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $105 | $71.33 | +47.20% | 7 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $215 | $240.46 | -10.59% | 15 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 | $197.38 | +26.66% | 6 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $44 | $54.50 | -19.27% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $8.55 | +63.74% | 4 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $103 → $115 | $95.30 | +20.67% | 14 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $98 | $90.97 | +7.73% | 4 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $390 | $579.65 | -32.72% | 6 | Jan 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $97.46 | -31.25% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $115 | $68.92 | +66.86% | 14 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $107.80 | +62.34% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $14.45 | +73.01% | 3 | May 13, 2020 |
Hologic
Nov 5, 2024
Maintains: Outperform
Price Target: $90 → $87
Current: $71.58
Upside: +21.54%
Teleflex
Nov 1, 2024
Maintains: Neutral
Price Target: $275 → $250
Current: $174.90
Upside: +42.94%
LivaNova
Oct 31, 2024
Maintains: Outperform
Price Target: $80 → $70
Current: $48.25
Upside: +45.08%
Boston Scientific
Oct 24, 2024
Maintains: Outperform
Price Target: $100 → $110
Current: $103.54
Upside: +6.24%
Abbott Laboratories
Oct 17, 2024
Maintains: Neutral
Price Target: $115 → $130
Current: $129.10
Upside: +0.70%
ADMA Biologics
Jun 20, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $16.90
Upside: -17.16%
Establishment Labs Holdings
Jun 6, 2024
Maintains: Buy
Price Target: $65 → $70
Current: $30.73
Upside: +127.83%
Alcon
May 15, 2024
Maintains: Buy
Price Target: $100 → $105
Current: $91.57
Upside: +14.67%
STAAR Surgical Company
May 8, 2024
Maintains: Buy
Price Target: $53 → $55
Current: $23.22
Upside: +136.86%
Lantheus Holdings
May 3, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $91.80
Upside: +8.93%
May 1, 2024
Maintains: Buy
Price Target: $110 → $105
Current: $86.93
Upside: +20.79%
Apr 11, 2024
Maintains: Neutral
Price Target: $20 → $16
Current: $5.13
Upside: +211.89%
Apr 11, 2024
Maintains: Neutral
Price Target: $85 → $100
Current: $154.32
Upside: -35.20%
Apr 11, 2024
Maintains: Buy
Price Target: $95 → $105
Current: $71.33
Upside: +47.20%
Mar 27, 2024
Maintains: Buy
Price Target: $215
Current: $240.46
Upside: -10.59%
Mar 27, 2024
Maintains: Buy
Price Target: $250
Current: $197.38
Upside: +26.66%
Mar 6, 2024
Maintains: Buy
Price Target: $30 → $44
Current: $54.50
Upside: -19.27%
Mar 1, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $8.55
Upside: +63.74%
Mar 1, 2024
Maintains: Buy
Price Target: $103 → $115
Current: $95.30
Upside: +20.67%
Feb 21, 2024
Maintains: Buy
Price Target: $95 → $98
Current: $90.97
Upside: +7.73%
Jan 25, 2024
Maintains: Neutral
Price Target: $350 → $390
Current: $579.65
Upside: -32.72%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $97.46
Upside: -31.25%
Feb 8, 2023
Maintains: Buy
Price Target: $110 → $115
Current: $68.92
Upside: +66.86%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $107.80
Upside: +62.34%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $14.45
Upside: +73.01%